Cargando…

Optimal radiation dose in the neoadjuvant management of esophageal cancer

Detalles Bibliográficos
Autor principal:	Buckstein, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475543/ https://www.ncbi.nlm.nih.gov/pubmed/32944377 http://dx.doi.org/10.21037/jtd.2020.04.23

Ejemplares similares

Revisiting the role of dose escalation in esophageal cancer in the era of modern radiation delivery
por: Eze, Chukwuka, et al.
Publicado: (2020)

Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
por: Lin, Jhen-Bin, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
por: Zhou, Qing, et al.
Publicado: (2023)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Optimizing management of patients with pancreatic exocrine insufficiency
por: Arvanitakis, Marianna, et al.
Publicado: (2023)

A biologically effective dose threshold for stereotactic body radiation therapy—can we put the issue to BED?
por: Mix, Michael, et al.
Publicado: (2020)

Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?
por: Robertson, Francis P., et al.
Publicado: (2023)

Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy
por: Koëter, Marijn, et al.
Publicado: (2015)

Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
por: Alite, Fiori, et al.
Publicado: (2020)

Comparison of Pathologic Complete Response Rates and Oncologic Outcomes in Patients With Surgically Resectable Esophageal Cancer Treated With Neoadjuvant Chemoradiation to 50.4 Gy vs 41.4 Gy
por: Nehlsen, Anthony D, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2018)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019)

Safe and Proper Management of Esophageal Stricture Using Endoscopic Esophageal Dilation
por: Hwang, Jae Jin
Publicado: (2017)

Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers
por: Ismaili, Nabil
Publicado: (2020)

Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
por: Tachibana, Isamu, et al.
Publicado: (2020)

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy
por: Ferraro, Emanuela, et al.
Publicado: (2020)

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
por: Mayer, Erica L, et al.
Publicado: (2007)

The prospective mathematical idea satisfying both radiation hormesis under low radiation doses and linear non-threshold theory under high radiation doses
por: Kino, Katsuhito
Publicado: (2020)

Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
por: Chau, Brittney, et al.
Publicado: (2019)

Managing Radiation Dose from Chest CT in COVID-19 Patients
por: Lee, Choonsik
Publicado: (2020)

Impact of age on optimal dose of antidepressants
por: Hashimoto, Kenji
Publicado: (2020)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

In search of goldilocks: the quest to optimize combination drug strategies for the management of advanced stage non-small-cell lung cancer
por: Bindal, Poorva, et al.
Publicado: (2020)

Evidence of a Dose Threshold for Radiation-Induced Leukemia
por: Cuttler, Jerry M.
Publicado: (2018)

The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding
por: Stanworth, Simon J, et al.
Publicado: (2011)

New Trends in Esophageal Cancer Management
por: Gronnier, Caroline, et al.
Publicado: (2021)

PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
por: Zhang, Liyi
Publicado: (2021)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

Low-dose radiation cancer susceptibility models
por: Mao, Jian-Hua, et al.
Publicado: (2015)

Optimizing frontline therapy in advanced urothelial cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

The Double Threshold: Consequences for Identifying Low-Dose Radiation Effects
por: Waltar, Alan, et al.
Publicado: (2020)

Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
por: Venkatesulu, Bhanu P, et al.
Publicado: (2020)

Caution warranted for low-dose radiation therapy for Covid-19
por: Das, Indra J, et al.
Publicado: (2021)

Heart Dose and Outcomes in Radiation Treatment for Esophageal Cancer
por: Macomber, Meghan W, et al.
Publicado: (2018)

Familial aggregation of esophageal cancer
por: Li, Shuai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g49n4421fqa2tdqs3e2i6ll7ib